Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan M Winter

Showing results (151-160 of 174) with videos related to

Pageof 18
Sort By:
Molecular Cancer Research : MCR|March 1, 2017
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal PhenotypeShruti Lal, Edwin C Cheung, Mahsa Zarei, et al.
Annals of Surgical Oncology|January 21, 2010
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu, Joseph M Herman, Michele M Corsini, et al.
Journal of Surgical Oncology|June 20, 2017
Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinomaJeffrey D Epstein, Geoffrey Kozak, Zhi Ven Fong, et al.
Molecular Cancer|May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square|May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Annals of Surgery|July 3, 2015
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional AnalysisJordan M Winter, Wei Jiang, Olca Basturk, et al.
Nature|July 8, 2011
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisGina M DeNicola, Florian A Karreth, Timothy J Humpton, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2018
Host <i>IDO2</i> Gene Status Influences Tumor Progression and Radiotherapy Response in <i>KRAS</i>-Driven Sporadic Pancreatic CancersAvinoam Nevler, Alexander J Muller, Erika Sutanto-Ward, et al.
Pageof 18

Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Molecular Cancer Research : MCR|March 1, 2017
CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal PhenotypeShruti Lal, Edwin C Cheung, Mahsa Zarei, et al.
Annals of Surgical Oncology|January 21, 2010
Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyCharles C Hsu, Joseph M Herman, Michele M Corsini, et al.
Journal of Surgical Oncology|June 20, 2017
Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinomaJeffrey D Epstein, Geoffrey Kozak, Zhi Ven Fong, et al.
Molecular Cancer|May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square|May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Annals of Surgery|July 3, 2015
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional AnalysisJordan M Winter, Wei Jiang, Olca Basturk, et al.
Nature|July 8, 2011
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisGina M DeNicola, Florian A Karreth, Timothy J Humpton, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2018
Host <i>IDO2</i> Gene Status Influences Tumor Progression and Radiotherapy Response in <i>KRAS</i>-Driven Sporadic Pancreatic CancersAvinoam Nevler, Alexander J Muller, Erika Sutanto-Ward, et al.
Pageof 18